In the further context of IBD, BAFF has emerged as a potentially significant biomarker, as studies have shown that patients with IBD, including both CD and UC, exhibit elevated levels of BAFF in serum, feces, and colonic tissues [89,120]. The gene discussed is TNFSF13B; the disease is inflammatory bowel disease.